Anna Norhammar

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

Anna Norhammar, Åke Tenerz, Göran Nilsson et al. · The Lancet · 2002 · 1.1K citations

Medicine, Cardiology, Internal Medicine +14

Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction

Klas Malmberg, Anna Norhammar, Hans Wedel et al. · Circulation · 1999 · 853 citations

Medicine, Cardiology, Internal Medicine +17

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs

Mikhail Kosiborod, Matthew A. Cavender, Alex Z. Fu et al. · Circulation · 2017 · 814 citations · Full text

Medicine, Cardiology, Pharmacology +16

Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs

Carolyn S.P. Lam, Shun Kohsaka, Avraham Karasik et al. · Journal of the American College of Cardiology · 2018 · 466 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis

Kåre I. Birkeland, Marit E. Jørgensen, Bendix Carstensen et al. · The Lancet Diabetes & Endocrinology · 2017 · 371 citations

Medicine, Internal Medicine, Pharmacotherapy +17